Comparative Pharmacology
Head-to-head clinical analysis: COLYTE FLAVORED versus CONSTILAC.
Peer-Reviewed Evidence
Head-to-head clinical analysis: COLYTE FLAVORED versus CONSTILAC.
COLYTE-FLAVORED vs CONSTILAC
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Colyte is an osmotic laxative that induces diarrhea by retaining water in the colon through non-absorbable polyethylene glycol (PEG) and electrolytes, resulting in bowel cleansing.
Constilac (lactulose) is a synthetic disaccharide that is not absorbed in the small intestine. In the colon, it is metabolized by bacteria to short-chain fatty acids (e.g., lactic acid), which osmotically draw water into the bowel, producing a laxative effect. Additionally, in hepatic encephalopathy, the acidification of colonic contents traps ammonia (NH3) as ammonium (NH4+), reducing its absorption.
4 liters orally as a single dose or in divided doses for colonoscopy preparation, or 1 liter orally every 10-15 minutes until 4 liters are consumed.
Oral, 15-45 mL (10-20 g lactulose) once daily, titrated to produce 2-3 soft stools daily; may be given as a single dose or divided twice daily. Onset of action 24-48 hours.
None Documented
None Documented
Not applicable; the drug acts locally in the gastrointestinal tract without significant systemic absorption. For the small fraction absorbed, a terminal elimination half-life of approximately 0.5-1 hour is estimated, but clinical relevance is negligible.
Not applicable due to negligible systemic absorption; lactulose acts locally in the colon.
Primarily eliminated in feces (≥95%) as intact drug via the gastrointestinal tract. Minimal systemic absorption; renal excretion accounts for <1% of the administered dose.
Primarily fecal as unchanged drug (systemic absorption negligible). Renal excretion accounts for <2% of any absorbed fraction. Biliary excretion is minimal.
Category C
Category C
Osmotic Laxative
Osmotic Laxative